CoChat

Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England

Stone, Margaret A, Mayberry, John F, Baker, Richard · 2003 · European Journal of Gastroenterology & Hepatology
Cited by 102

The DOI matches its Crossref record.

Abstract

OBJECTIVES: To estimate the prevalence of inflammatory bowel disease (IBD) from the information in general practitioners' records and to describe patient management, including the prescribing of 5-aminosalicylates and adherance to treatment in ulcerative colitis, and frequency of advice given concerning cessation of smoking. METHODS: Fifteen general practices were recruited through the Trent Focus Collaborative Research Network, UK, to take part in a cross-sectional study. They identified confirmed cases of IBD and used a pro-forma to collect data for collation and analysis. RESULTS: Searches identified 344 IBD cases from a combined list of 86 801 patients, suggesting a prevalence of 396 per 100 000 (95% confidence interval, 356-440). Practices considered 32% of patients to be under the sole care of general practitioners; only 59% had been seen in secondary care during the previous year and the numbers of outpatient and general practitioner consultations were similar. Smoking cessation advice was documented for similar numbers of smokers with Crohn's disease and ulcerative colitis. Excluding patients who had undergone surgery, only 65% of patients with ulcerative colitis had been prescribed a 5-aminosalicylate in the previous 6 months and good treatment adherence was suggested in only 42% of ulcerative colitis patients taking a 5-aminosalicylate. Prescribing of aminosalicylates was more common in patients under specialist or shared care than those under general practitioner care only; this remained significant in a regression model also including extent of disease (P < 0.0001). CONCLUSIONS: General practitioners play an important role in caring for patients with IBD and may need relevant education and support. Aminosalicylates appear to be under-used in patients with ulcerative colitis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00042737-200312000-00004

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 22

  1. Rubin, 2000, Aliment Pharmacol Ther, 14, 1553, 10.1046/j.1365-2036.2000.00886.x · DOI · Paper page
  2. Devlin, 1980, World J Surg, 4, 183, 10.1007/BF02393573 · DOI
  3. Ekbom, 1990, N Engl J Med, 323, 1228, 10.1056/NEJM199011013231802 · DOI · Paper page
  4. Moum, 1999, Am J Gastroenterol, 94, 1564, 10.1111/j.1572-0241.1999.01145.x · DOI
  5. Eaden, 2001, Gut, 48, 526, 10.1136/gut.48.4.526 · DOI · Paper page
  6. Eaden, 2000, Aliment Pharmacol Ther, 14, 145, 10.1046/j.1365-2036.2000.00698.x · DOI · Paper page
  7. Pinczowski, 1994, Gastroenterology, 107, 117, 10.1016/0016-5085(94)90068-X · DOI · Paper page
  8. Moody, 1996, Eur J Gastroenterol Hepatol, 8, 1179, 10.1097/00042737-199612000-00009 · DOI · Paper page
  9. Rubin, 2002, Aliment Pharmacol Ther, 16, 1889, 10.1046/j.1365-2036.2002.01370.x · DOI
  10. Hammersley, 2002, Br J Gen Prac, 52, 463
  11. Baker, 2000, Br J Gen Prac, 50, 655
  12. Eaden, 2002, Gut, 51, v10, 10.1136/gut.51.suppl_5.v10 · DOI · Paper page
  13. Axon, 1994, Gastroenterology, 106, 1129, 10.1016/0016-5085(94)90785-4 · doi:10.1016/0016-5085(94)90785-4
  14. Moody, 1993, J R Soc Med, 86, 26
  15. Read, 1999, Postgrad Med J, 75, 147, 10.1136/pgmj.75.881.147 · doi:10.1136/pgmj.75.881.147
  16. Robinson, 2001, Lancet, 358, 976, 10.1016/S0140-6736(01)06105-0 · DOI · Paper page
  17. Moayyedi, 2002, Gut, 51, 309, 10.1136/gut.51.3.309 · doi:10.1136/gut.51.3.309
  18. Harries, 1982, Br Med J, 284, 706, 10.1136/bmj.284.6317.706 · DOI · Paper page
  19. Sommerville, 1984, Br Med J, 289, 954, 10.1136/bmj.289.6450.954 · DOI · Paper page
  20. Duffy, 1990, Am J Prev Med, 98, 1123
  21. Rhodes, 1994, Gastroenterology, 106, 807, 10.1016/0016-5085(94)90719-6 · DOI
  22. Shaw, 2002, Aliment Pharmacol Ther, 16, 2053, 10.1046/j.1365-2036.2002.01375.x · doi:10.1046/j.1365-2036.2002.01375.x

Cited by

See all 102

Metadata

Authors
Stone, M. A., Mayberry, J. F., & Baker, R.
Venue
European Journal of Gastroenterology & Hepatology
Published
2003-12
Volume
15
Issue
12
Pages
1275-1280
ISSN
0954-691X (ISSN-L)
OpenAlex
W2039990880
Cited by
102
References
0
FWCI
1.51
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. https://app.cochat.ai/papers/10.1097/00042737-200312000-00004
The paper
Stone, M. A., Mayberry, J. F., & Baker, R. (2003). Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/00042737-200312000-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.